We have also recently reported that E2 even at a low dose provides highly significant therapeutic efficacy for amelioration of neurodegeneration and recovery of locomotor function in animal models of acute SCI (Samantaray et al., 2016a) and chronic SCI (Samantaray et al., 2016b).
← all excerpts
Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury.
1
—
—